Published on in Vol 23, No 12 (2021): December
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/34051, first published
.
![Citation Advantage of Promoted Articles in a Cross-Publisher Distribution Platform: 36-Month Follow-up to a Randomized Controlled Trial Citation Advantage of Promoted Articles in a Cross-Publisher Distribution Platform: 36-Month Follow-up to a Randomized Controlled Trial](https://asset.jmir.pub/assets/d8f599374f41ec0ff6e00c98a606fda7.png 480w,https://asset.jmir.pub/assets/d8f599374f41ec0ff6e00c98a606fda7.png 960w,https://asset.jmir.pub/assets/d8f599374f41ec0ff6e00c98a606fda7.png 1920w,https://asset.jmir.pub/assets/d8f599374f41ec0ff6e00c98a606fda7.png 2500w)
1 Department of Psychiatry, University of Toronto, Toronto, ON, Canada
2 TrendMD Inc., Toronto, ON, Canada
3 University of Victoria, Victoria, BC, Canada
*all authors contributed equally